{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:36:21Z","timestamp":1788496581563,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1124\/jpet.111.183285","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T02:07:50Z","timestamp":1313633270000},"page":"324-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Drug Discontinuation Effects Are Part of the Pharmacology of a Drug"],"prefix":"10.1016","volume":"339","author":[{"given":"Marcus M.","family":"Reidenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.183285_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-81-5-625","article-title":"Coronary artery syndromes after sudden propranolol withdrawal","volume":"81","author":"Alderman","year":"1974","journal-title":"Ann Int Med"},{"key":"10.1124\/jpet.111.183285_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0735-1097(01)01825-3","article-title":"Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin","volume":"39","author":"Bijsterveld","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.111.183285_bib3","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.jacc.2003.05.014","volume":"42","author":"Bijsterveld","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.111.183285_bib4","first-page":"255","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria","volume":"25","author":"Black","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/jpet.111.183285_bib5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/01.wnl.0000269789.09277.47","article-title":"Statin treatment withdrawal in ischemic stroke: a controlled randomized study","volume":"69","author":"Blanco","year":"2007","journal-title":"Neurology"},{"key":"10.1124\/jpet.111.183285_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijcard.2007.10.044","article-title":"Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase","volume":"131","author":"Chen","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1124\/jpet.111.183285_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0167-5273(00)00399-5","article-title":"Myocardial infarction after aspirin cessation in stable coronary artery disease patients","volume":"76","author":"Collet","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1124\/jpet.111.183285_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1592\/phco.26.9.1288","article-title":"Statin withdrawal: clinical implications and molecular mechanisms","volume":"26","author":"Cubeddu","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1124\/jpet.111.183285_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000474198","article-title":"The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT Group","volume":"30","author":"Debruyne","year":"1996","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.111.183285_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0026-895X(25)08974-6","article-title":"Class I and IV antiarrhythmic drugs and cytosolic calcium regulate mRNA encoding the sodium channel alpha subunit in rat cardiac muscle","volume":"42","author":"Duff","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.183285_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2003.12.041","article-title":"Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study","volume":"117","author":"Eagle","year":"2004","journal-title":"Am J Med"},{"key":"10.1124\/jpet.111.183285_bib12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/oxfordjournals.eurheartj.a015070","article-title":"Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?","volume":"17","author":"Fatah","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.111.183285_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2005.04.029","article-title":"Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality","volume":"96","author":"Fonarow","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.111.183285_bib14","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.1997.00440400055007","article-title":"Adverse events after discontinuing medications in elderly outpatients","volume":"157","author":"Graves","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1124\/jpet.111.183285_bib15","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1161\/01.CIR.0000050552.32300.93","article-title":"Withdrawal of statins in patients with acute coronary syndromes","volume":"107","author":"Heeschen","year":"2003","journal-title":"Circulation"},{"key":"10.1124\/jpet.111.183285_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","article-title":"Withdrawal of statins increases event rates in patients with acute coronary syndromes","volume":"105","author":"Heeschen","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.111.183285_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/er.2001-0014","article-title":"Endocrine withdrawal syndromes","volume":"24","author":"Hochberg","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.111.183285_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-8703(81)90317-3","article-title":"Abrupt cessation of treatment in hypertension: consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome","volume":"102","author":"Houston","year":"1981","journal-title":"Am Heart J"},{"key":"10.1124\/jpet.111.183285_bib19","series-title":"The Pharmacologic Basis of Therapeutics","first-page":"550","article-title":"Drug addiction and drug abuse","author":"Jaffe","year":"1980"},{"key":"10.1124\/jpet.111.183285_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinte.161.9.1145","article-title":"Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards","volume":"161","author":"Kizer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1124\/jpet.111.183285_bib21","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0002-9149(01)02095-1","article-title":"Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men","volume":"88","author":"Laufs","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.111.183285_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0090-4295(98)00127-7","article-title":"Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group","volume":"51","author":"Lepor","year":"1998","journal-title":"Urology"},{"key":"10.1124\/jpet.111.183285_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pharmthera.2009.03.019","article-title":"Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence","volume":"123","author":"Lordkipanidz\u00e9","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.111.183285_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0090-4295(94)80008-1","article-title":"(1994) Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis","volume":"44","author":"Lowe","year":"1994","journal-title":"Urology"},{"key":"10.1124\/jpet.111.183285_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0262-1746(83)90002-1","article-title":"Recovery of cyclooxygenase activity after aspirin in populations of platelets separated on stractan density gradients","volume":"12","author":"McDonald","year":"1983","journal-title":"Prostaglandins Leukot Med"},{"key":"10.1124\/jpet.111.183285_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000175993","article-title":"Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1","volume":"83","author":"Mousa","year":"1993","journal-title":"Cardiology"},{"key":"10.1124\/jpet.111.183285_bib27","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1056\/NEJMp0912651","article-title":"Health care reform and the need for comparative-effectiveness research","volume":"362","author":"Mushlin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.183285_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199307013290101","article-title":"Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study","volume":"329","author":"Packer","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1124\/jpet.111.183285_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.283.6292.643","article-title":"Withdrawal from long-term benzodiazepine treatment","volume":"283","author":"Petursson","year":"1981","journal-title":"Br Med J"},{"key":"10.1124\/jpet.111.183285_bib30","series-title":"Renal Function and Drug Action","author":"Reidenberg","year":"1971"},{"key":"10.1124\/jpet.111.183285_bib31","first-page":"905","article-title":"Individualization of drug therapy","volume":"58","year":"1974","journal-title":"Med Clin North Am"},{"key":"10.1124\/jpet.111.183285_bib32","first-page":"969","article-title":"Clinical pharmacology of symptom control","volume":"66","year":"1982","journal-title":"Med Clin North Am"},{"key":"10.1124\/jpet.111.183285_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cpt1978234371","article-title":"Relationship between diazepam dose, plasma level, age, and central nervous system depression","volume":"23","author":"Reidenberg","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.111.183285_bib34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM196809262791304","article-title":"Adverse nondrug reactions","volume":"279","author":"Reidenberg","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.183285_bib35","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1161\/STROKEAHA.109.552760","article-title":"Withdrawal of statins and risk of subarachnoid hemorrhage","volume":"40","author":"Risselada","year":"2009","journal-title":"Stroke"},{"key":"10.1124\/jpet.111.183285_bib36","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.491423","article-title":"Effects of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans","volume":"38","author":"Rosengarten","year":"2007","journal-title":"Stroke"},{"key":"10.1124\/jpet.111.183285_bib37","series-title":"Drugs and Narcotics in History","first-page":"17","article-title":"The opium poppy in Hellenistic and Roman medicine","author":"Scarborough","year":"1995"},{"key":"10.1124\/jpet.111.183285_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.amjcard.2007.02.093","article-title":"Effect of statin withdrawal on frequency of cardiac events after vascular surgery","volume":"100","author":"Schouten","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.111.183285_bib39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000118288.04483.02","article-title":"Antiplatelet drug discontinuation is a risk factor for ischemic stroke","volume":"62","author":"Sibon","year":"2004","journal-title":"Neurology"},{"key":"10.1124\/jpet.111.183285_bib40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(73)90235-3","article-title":"Withdrawal of propranolol and myocardial infarction","volume":"1","author":"Slome","year":"1973","journal-title":"Lancet"},{"key":"10.1124\/jpet.111.183285_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2009.04.008","article-title":"Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal","volume":"207","author":"Sposito","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.111.183285_bib42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bmj.286.6364.520","article-title":"Calcium antagonist withdrawal syndrome: objective demonstration with frequency-modulated ambulatory ST-segment monitoring","volume":"286","author":"Subramanian","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1124\/jpet.111.183285_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-152-1-201001050-00179","article-title":"Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial","volume":"152","author":"Sung","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.111.183285_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199207163270301","article-title":"Reactivation of unstable angina after the discontinuation of heparin","volume":"327","author":"Th\u00e9roux","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.183285_bib45","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(05)79893-7","article-title":"Increased thrombotic vascular events after change of statin","volume":"352","author":"Thomas","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/jpet.111.183285_bib46","first-page":"157","article-title":"Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1\u03b1 excretion after aspirin withdrawal","volume":"21A","author":"Vial","year":"1991","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1124\/jpet.111.183285_bib47","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"10.1124\/jpet.111.183285_bib48","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0024-3205(88)90587-5","article-title":"Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE","volume":"43","author":"Yoburn","year":"1988","journal-title":"Life Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524465993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524465993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.183285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:37:51Z","timestamp":1743201471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524465993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0022356524465993"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.183285","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Discontinuation Effects Are Part of the Pharmacology of a Drug","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.183285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}